Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Berger R, Frey B, Hülsmann M, Koller-Strametz J, Pacher R, Sima I, Stanek B
Delayed effects of one-year treatment with low-dose as compared with high-dose enalapril on morbidity and mortality of patients with severe heart failure
Journal of Clinical and Basic Cardiology 1998; 1 (1): 19-24

PDF    Summary    Overview   

Fig. 1: Enalapril bei schwerer Herzinsuffizienz - Design Fig. 2: Enalapril bei schwerer Herzinsuffizienz - NYHA Fig. 3: Enalapril bei schwerer Herzinsuffizienz - Blutdruck, Plasmakreatinin This Image - Fig. 4: Enalapril bei schwerer Herzinsuffizienz - Studienpopulation Fig. 5: Enalapril bei schwerer Herzinsuffizienz - Überleben
Figure/Graphic 4: Enalapril bei schwerer Herzinsuffizienz - Studienpopulation
Number of all randomized patients (all patients-treated cohort and study completing cohort) and number of drop outs at month 0, 15, 18, 24, 30 and 36, as allocated to the low-dose extension group and to the high-dose extension group.
 
Enalapril bei schwerer Herzinsuffizienz - Studienpopulation
Previous Image Next Image   


Figure/Graphic 4: Enalapril bei schwerer Herzinsuffizienz - Studienpopulation
Number of all randomized patients (all patients-treated cohort and study completing cohort) and number of drop outs at month 0, 15, 18, 24, 30 and 36, as allocated to the low-dose extension group and to the high-dose extension group.
 
copyright © 2000–2025 Krause & Pachernegg GmbH | Sitemap | Datenschutz | Impressum
 
Werbung